Abstract
ABSTRACTSore throat is one of the most common complaints encountered in the ambulatory clinical setting. Rapid, culture-independent diagnostic techniques that do not rely on pharyngeal swabs would be highly valuable as a point-of-care strategy to guide outpatient antibiotic treatment. Despite the promise of this approach, efforts to detect volatiles during oropharyngeal infection have yet been limited. In our research study, we sought to evaluate for specific bacterial volatile organic compounds (VOC) biomarkers in isolated culturesin vitro, in order to establish proof-of-concept prior to initial clinical studies of breath biomarkers. A particular challenge for diagnosis of pharyngitis due toStreptococcus pyogenesis the likelihood that many metabolites may be shared byS. pyogenesand other related oropharyngeal colonizing bacterial species. Therefore, we evaluated whether sufficient metabolic differences are present that distinguish the volatile metabolome of Group A streptococci from other streptococcal species that also colonize the respiratory mucosa, such asS. pneumoniaeandS. intermedius. In this work, we identify candidate biomarkers that distinguishS. pyogenesfrom other species, and establish highly produced VOCs that indicate presence ofS. pyogenes in vitro, supporting future breath-based diagnostic testing for streptococcal pharyngitis.IMPORTANCEAcute pharyngitis accounts for approximately 15 million ambulatory care visits in the USA. The most common and important bacterial cause of pharyngitis isStreptococcus pyogenesis, accounting for 15% to 30% of pediatric pharyngitis. Distinguishing between bacterial and viral pharyngitis is key to management in US practice. Culture of a specimen obtained by throat swab is the standard laboratory procedure for the microbiologic confirmation of pharyngitis, however this method is time consuming which delays appropriate treatment. If left untreated,S. pyogenespharyngitis may lead to local and distant complications. In this study, we characterized the volatile metabolomes ofS. pyogenesand other related oropharyngeal colonizing bacterial species. We identify candidate biomarkers that distinguishS. pyogenesfrom other species and provides evidence to support future breath-based diagnostic testing for streptococcal pharyngitis.
Publisher
Cold Spring Harbor Laboratory
Reference37 articles.
1. Shulman ST et al (Clin Infect Dis 2012; 55: e86-e102)
2. Luo R , Sickler J , Vahidnia F , Lee YC , Frogner B , Thompson M . 2019. Diagnosis and Management of Group a Streptococcal Pharyngitis in the United States, 2011-2015. Bmc Infectious Diseases 19.
3. Bacterial Prevalence and Antimicrobial Prescribing Trends for Acute Respiratory Tract Infections;Pediatrics,2014
4. Anonymous. 2017. CDC. Antibiotic Use in the United States, 2017: Progress and Opportunities. Atlanta, GA: US Department of Health and Human Services, CDC,
5. Detection of Mastitis Pathogens by Analysis of Volatile Bacterial Metabolites